SCHEMBL31090708

SCHEMBL31090708

COc1cc(-c2ccccc2C(SC(c2ccccc2)(c2ccccc2)c2ccccc2-c2cc(OC)c(OC)c(OC)c2)(c2ccccc2)c2ccccc2)cc(OC)c1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FYN P06241 2/20 0.43
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
HPGD P15428 1/20 0.41
BRD4 O60885 4/20 0.40
HSD17B10 Q99714 1/20 0.40
TUBB4A P04350 3/20 0.40
TUBB P07437 3/20 0.40
TUBA3C P0DPH7 3/20 0.40
TUBA1B P68363 3/20 0.40
TUBA4A P68366 3/20 0.40
TUBB4B P68371 3/20 0.40
TUBB3 Q13509 3/20 0.40
TUBB2A Q13885 3/20 0.40
TUBB8 Q3ZCM7 3/20 0.40
TUBA3E Q6PEY2 3/20 0.40
TUBA1A Q71U36 3/20 0.40
TUBA1C Q9BQE3 3/20 0.40
TUBB6 Q9BUF5 3/20 0.40
TUBB2B Q9BVA1 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31090715 0.82 ABL1 (0.50) MEN1MAPTKMT2ASMN1; SMN2KIF11
SCHEMBL31090719 0.78 ABL1 (0.47) ALDH1A1KDM4EMAPTKIF11
SCHEMBL1126000 0.76 CA1 (0.44) ALDH1A1HTTMEN1KMT2AMAPK1
SCHEMBL31724007 0.72 TUBB4A (0.46) ALDH1A1KDM4EHPGDTUBB4ATUBB
SCHEMBL13813534 0.70 ADORA3 (0.52) FYNALDH1A1KDM4EHPGDBRD4
SCHEMBL31090699 0.69 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDHTTMEN1
SCHEMBL31090724 0.69 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDHTTMEN1
SCHEMBL31090714 0.69 PTGS2 (0.38) KIF11
SCHEMBL31090720 0.69 CYP1A2 (0.42) ALDH1A1KDM4EHSD17B10MEN1KMT2A
Methoxy Aucuparin SCHEMBL8420787 0.69 KDM4E (0.62) FYNALDH1A1KDM4EHPGDTUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4678632-A1 METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP AGC Inc. (JP) 2026-01-14 EP disclosed
US-20250346557-A1 METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP AGC Inc. (JP) 2025-11-13 US disclosed
WO-2024185814-A1 METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP AGC株式会社 2024-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250346557-A1 METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP STS, TST, CYP3A5 FYN 204/4885ALDH1A1 358/4885KDM4E 1282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.